Acenxion Biosystems is a diagnostic partner with public health laboratories, hospitals, and clinics, providing scalable, automated AST systems that reduce the time for phenotypic AST results from days to hours. Their technology allows clinicians to rapidly use targeted treatments, minimizing antibiotic exposure and limiting Anti-Microbial Resistance (AMR). Acenxion focuses on delivering fast and accurate phenotypic Antimicrobial Susceptibility Testing (AST) results to assist patients in receiving effective treatments and mitigating AMR risks. They are committed to gold-standard phenotypic results, cost-effective medical device technology, and long-term antibiotic stewardship.